Literature DB >> 27021424

Characteristics and prognosis of pneumococcal endocarditis: a case-control study.

M Daudin1, P Tattevin2, B Lelong1, E Flecher1, S Lavoué3, C Piau4, A Ingels1, A Chapron5, J-C Daubert1, M Revest6.   

Abstract

Case series have suggested that pneumococcal endocarditis is a rare disease, mostly reported in patients with co-morbidities but no underlying valve disease, with a rapid progression to heart failure, and high mortality. We performed a case-control study of 28 patients with pneumococcal endocarditis (cases), and 56 patients with non-pneumococcal endocarditis (controls), not matched for sex and age, during the years 1991-2013, in one referral centre. Alcoholism (39.3% versus 10.7%; p <0.01), smoking (60.7% versus 21.4%; p <0.01), the absence of previously known valve disease (82.1% versus 60.7%; p 0.047), heart failure (64.3% versus 23.2%; p <0.01) and shock (53.6% versus 23.2%; p <0.01) were more common in pneumococcal than in non-pneumococcal endocarditis. Cardiac surgery was required in 64.3% of patients with pneumococcal endocarditis, much earlier than in patients with non-pneumococcal endocarditis (mean time from symptom onset, 14.1 ± 18.2 versus 69.0 ± 61.1 days). In-hospital mortality rates were similar (7.1% versus 12.5%). Streptococcus pneumoniae causes rapidly progressive endocarditis requiring life-saving early cardiac surgery in most cases.
Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cardiac surgery; Streptococcus pneumoniae; case–control study; endocarditis; heart failure

Mesh:

Year:  2016        PMID: 27021424     DOI: 10.1016/j.cmi.2016.03.011

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  1 in total

1.  A Rare Case of Aortoatrial Fistula from Streptococcal Endocarditis.

Authors:  Hammad Arshad; Meilin Young; Parth Rali
Journal:  Case Rep Pulmonol       Date:  2017-07-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.